new_0222_0567|ATHA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0567|ATHA|1|Athira Pharma Inc Total Current Assets (Quarterly) (USD)|Athira Pharma Inc Cash and Short Term Investments (Quarterly) (USD)|Athira Pharma Inc Inventories (Quarterly) (USD)|Athira Pharma Inc Net PP&E (Quarterly) (USD)|Athira Pharma Inc Goodwill and Intangibles (Quarterly) (USD)|Athira Pharma Inc Total Liabilities (Quarterly) (USD)|Athira Pharma Inc Total Current Liabilities (Quarterly) (USD)|Athira Pharma Inc Total Long Term Liabilities (Quarterly) (USD)|Athira Pharma Inc Total Deposits (Quarterly) (USD)|Athira Pharma Inc Book Value (Quarterly) (USD)|Athira Pharma Inc Retained Earnings (Quarterly) (USD)|Athira Pharma Inc Treasury Stock (Quarterly) (USD)|Athira Pharma Inc EV to Revenues|Athira Pharma Inc EV to Earnings|Athira Pharma Inc EV to Free Cash Flow|Athira Pharma Inc EV to Assets (Quarterly)|Athira Pharma Inc PS Ratio|Athira Pharma Inc PE Ratio|Athira Pharma Inc Price to Book Value|Athira Pharma Inc PEG Ratio|Athira Pharma Inc Debt to Equity Ratio|Athira Pharma Inc Dividend Yield|Athira Pharma Inc Shareholder Yield (TTM)|Athira Pharma Inc Percent of Shares Outstanding Short|Athira Pharma Inc Total Receivables (Quarterly) (USD)|Athira Pharma Inc Total Payables (Quarterly) (USD)|Athira Pharma Inc Total Capital Stock (Quarterly) (USD)|Athira Pharma Inc Return on Invested Capital|Athira Pharma Inc Quality Ratio Score|Athira Pharma Inc Momentum Score|Athira Pharma Inc Beta (1Y)|Athira Pharma Inc Sustainable Growth Rate (TTM)|Athira Pharma Inc Institutional Investor Ownership Percentage|Athira Pharma Inc Average Diluted Shares Outstanding (Quarterly)|Athira Pharma Inc Total Employees (Annual)|Athira Pharma Inc EPS Diluted (Quarterly) (USD)|Athira Pharma Inc Shares Outstanding|Athira Pharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Athira Pharma Inc Ordinary Shares Number (Quarterly)|Athira Pharma Inc Payout Ratio|Athira Pharma Inc Quick Ratio (Quarterly)|Athira Pharma Inc Normalized Diluted EPS (Quarterly) (USD)|Athira Pharma Inc Stock Buybacks (Quarterly) (USD)|Athira Pharma Inc Effective Tax Rate (TTM)|Athira Pharma Inc Return on Equity|Athira Pharma Inc Net Income (TTM) (USD)|Athira Pharma Inc Revenue (TTM) (USD)|Athira Pharma Inc Dividend Per Share (Quarterly) (USD)|Athira Pharma Inc Revenue (Quarterly) (USD)|Athira Pharma Inc Gross Profit (Quarterly) (USD)|Athira Pharma Inc SG&A Expense (Quarterly) (USD)|Athira Pharma Inc Pre-Tax Income (Quarterly) (USD)|Athira Pharma Inc Net Income (Quarterly) (USD)|Athira Pharma Inc Net Interest Income (Quarterly) (USD)|Athira Pharma Inc Price (USD)|Athira Pharma Inc Total Return Price (USD)|Athira Pharma Inc Enterprise Value (USD)|Athira Pharma Inc 30-Day Average Daily Volume|Athira Pharma Inc 1 Year Price Returns (Daily)||
new_0222_0567|ATHA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0567|ATHA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0567|ATHA|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44839857651|0|0|0|1.44759206799|0|0|1.44759206799|0|15.25|106.5|106.5|106.5|0|0|30.6666666667|30.75|0|30.5|91.375|184|91.375|27.8|0|106.5|0|0|91.375|91.3333333333|0|0|91.4|0|0|0|0|91.375|91.375|91.375|91.375|1.44759206799|1.44759206799|1.44759206799|1.45061728395|1.42574257426||
new_0222_0567|ATHA|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|281|0|0|0|353|0|0|353|0|32|6|6|6|0|0|3|4|0|14|8|1|8|15|0|6|0|0|8|6|0|0|5|0|0|0|0|8|8|8|8|353|353|353|324|101||
new_0222_0567|ATHA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0567|ATHA|201909||||||||||||||||||||||||||||||||||8.6035||-0.1778||||||-0.1689|||||||||0.509|-1.53|-1.53|-0.086|||||||
new_0222_0567|ATHA|201912|2.16|2.056||0||21.912|1.273|20.639||-19.723|-21.087||||||||||||||0.007|0.421|0|||||||8.6035||-0.1132|||28.8146|||-0.1147|||||||||0.459|-0.974|-0.974|-0.103|||||||
new_0222_0567|ATHA|202003||||||||||||||||||||||||||||||||||8.6035||-0.2098||||||-0.1581|0||||||||0.675|-1.805|-1.805|-0.212|||||||
new_0222_0567|ATHA|202006|84.973|83.666||0.017||5.512|5.512|0||79.919|-25.337||||||||||||||0.007|4.255|0.002|||||||28.8146|15|-0.0691|||28.8146|||-0.0869|0|||-6.301|||||0.575|-1.992|-1.992|-0.144|||||||
new_0222_0567|ATHA|202009|232.266|226.272||1.962||8.469|7.554|0.915||259.47|-33.34||||||||2.2117|||0||1.5286|0|3.872|0.003||||||71.0995|7.5645||-1.12|31.0874||31.0874|||-1.0353|-187.224|||-13.227|||||1.567|-8.456|-8.456|0.035|18.46|18.46|347.6014|276221.7||18.06|24.9
new_0222_0567|ATHA|202012|192.337|184.682||3.585||5.281|4.405|0.876||274.282|-41.042||||-38.4837||||4.0566|||0||3.1524|1.3|1.158|0.003||||||77.1766|32.4858|22|-0.2373|32.4858||32.4858|||-0.2373|-21.293|||-19.955|||||3.892|-7.702|-7.702|0.078|34.25|34.25|927.9566|257394.0333||21.32|22.06
new_0222_0567|ATHA|202103|311.568|304.19||4.324||6.197|4.497|1.7||363.217|-49.908||||-12.5442||||1.882|||0||2.507|2.906|1.687|0.004|||||||35.7755||-0.25|37.1503||37.1503|||-0.25|-97.172|||-27.016|||||3.336|-8.866|-8.866|0.084|18.4|18.4|379.3755|355899.6333||19.68|19.94
new_0222_0567|ATHA|202106|290.497|284.94||4.463||9.415|7.634|1.781||350.709|-63.882||||-2.5782||||1.0877|||0||3.2589|2.589|1.166|0.004|||||||37.2146||-0.38|37.2517||37.2517|||-0.38|0.41|||-38.998|||||4.613|-13.974|-13.974|0.074|10.24|10.24|96.5174|2096286.4667||9.61|10.59
new_0222_0567|ATHA|202109|238.992|235.775||4.565||11.094|9.386|1.708||336.237|-79.556||||-2.9848||||1.042|||0||3.0413|2.079|0.959|0.004|||2|3.3261||85.5458|37.3124||-0.42|37.3511||37.3511|||-0.42|0|||-46.216|||||7.119|-15.674|-15.674|0.073|9.38|9.38|114.5783|308291.3667|-49.1874|13.07|13.48
new_0222_0567|ATHA|202112|||||||||||||||-6.5363||||1.4474|||0||5.4541||||||2|3.19||86.6862||||||||||||||||||||||13.03|13.03|250.9098|349207.9667|-61.9562|10.3|10.1